The modified BODE index: validation with mortality in COPD
- PMID: 18579541
- DOI: 10.1183/09031936.00138507
The modified BODE index: validation with mortality in COPD
Abstract
Peak oxygen uptake (V'(O(2))) remains the gold standard measurement of exercise capacity and has been associated with survival. A modified BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) index replacing the 6-min walk distance (6MWD) with V'(O(2)) as % predicted (mBODE%) has been developed and found to have excellent correlation with the conventional BODE index. The objectives of the present study were to compare the ability of the conventional BODE and the mBODE% to predict mortality in 444 patients with chronic obstructive pulmonary disease (COPD) followed for a mean+/-SD period of 71+/-34 months. Anthropometrics, spirometry, lung volumes, comorbidity, cardiopulmonary cyclo-ergometry test and 6MWD were determined at entry. The mean BODE indices for the cohort were: BODE 4.1+/-2 and mBODE% 5.5+/-2. Both indices were significantly correlated with mortality. Logistic regression analysis with COPD survival as the dependent variable identified the BODE index, Charlson's and exercise capacity (in W) as variables associated with this outcome. In conclusion, the conventional BODE index, which uses the 6-min walk distance, predicts mortality in chronic obstructive pulmonary disease as well as the modified index using peak oxygen uptake. The results support the use of the simpler index, which includes the 6-min walk distance in the comprehensive evaluation of patients with chronic obstructive pulmonary disease.
Similar articles
-
A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD.Respir Med. 2011 Feb;105(2):266-73. doi: 10.1016/j.rmed.2010.06.022. Epub 2010 Jul 22. Respir Med. 2011. PMID: 20655186
-
Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.Chest. 2007 Aug;132(2):477-82. doi: 10.1378/chest.07-0435. Epub 2007 May 15. Chest. 2007. PMID: 17505032
-
Correlation between serum biomarkers and BODE index in patients with stable COPD.Respirology. 2009 Sep;14(7):999-1004. doi: 10.1111/j.1440-1843.2009.01608.x. Respirology. 2009. PMID: 19740260
-
Predictors of mortality in COPD.Respir Med. 2010 Jun;104(6):773-9. doi: 10.1016/j.rmed.2009.12.017. Epub 2010 Apr 22. Respir Med. 2010. PMID: 20417082 Review.
-
[Therapeutic goals and outcome measurements in COPD patients].Med Klin (Munich). 2006 Apr 15;101(4):279-82. doi: 10.1007/s00063-006-1035-7. Med Klin (Munich). 2006. PMID: 16607483 Review. German.
Cited by
-
Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?Drugs. 2012 Feb 12;72(3):301-8. doi: 10.2165/11598580-000000000-00000. Drugs. 2012. PMID: 22316346 Review.
-
Influence of physical activity on the prognosis of COPD patients: the HADO.2 score - health, activity, dyspnoea and obstruction.ERJ Open Res. 2024 Jan 15;10(1):00488-2023. doi: 10.1183/23120541.00488-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38226063 Free PMC article.
-
Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis.J Cachexia Sarcopenia Muscle. 2020 Oct;11(5):1164-1176. doi: 10.1002/jcsm.12600. Epub 2020 Aug 30. J Cachexia Sarcopenia Muscle. 2020. PMID: 32862514 Free PMC article.
-
Optimizing the 6-min walk test as a measure of exercise capacity in COPD.Chest. 2012 Dec;142(6):1545-1552. doi: 10.1378/chest.11-2702. Chest. 2012. PMID: 23364913 Free PMC article. Clinical Trial.
-
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Eur Respir Rev. 2015. PMID: 26028628 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical